FDA NDC Directory · JSON-LD · Markdown

Nystatin

NDC 51672-4117 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Labeler / ManufacturerTaro Pharmaceuticals U.S.A., Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA062876
Dosage form / routeSUSPENSION · ORAL
Active ingredientsNYSTATIN (100000 [USP'U]/mL)
Marketing started19880229
Package count3

External sources

Source: openFDA. Public-domain (CC0).